Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eva Renee Barnett Insider Profile
4 Followers
Eva Renee Barnett, CFO at Immunovant, holds 355.41K shares in Immunovant (Ticker: IMVT). Most recently, Eva Renee Barnett Sold $4,042 shares of Immunovant on May 24, 2024 for an estimated value of 119.85K.
Profitable Transactions
7 out of 13 Profitable Transactions
Average Return
-40.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Eva Renee Barnett's holdings
Insider Roles
CFO
Roles that Eva Renee Barnett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eva Renee Barnett
Eva Renee Barnett's Trading History
List of latest transactions for each holding click on a transaction to see Eva Renee Barnett's performance on stock
You May Also Like
Eva Renee Barnett insider profile FAQ
What is the percentage of profitable transactions made by Eva Renee Barnett?
The percentage of profitable transactions made by Eva Renee Barnett is 54%.
What is the average return per transaction made by Eva Renee Barnett?
The average return per transaction made by Eva Renee Barnett is -40.60%.
What stocks does Eva Renee Barnett hold?
Eva Renee Barnett holds: IMVT stocks.
What was Eva Renee Barnett’s latest transaction?
Eva Renee Barnett latest transaction was an Informative Sell of $119.85K.
What was Eva Renee Barnett's most profitable transaction?
Eva Renee Barnett’s most profitable transaction was an Informative Sell of IMVT stock on January 12, 2024. The return on the trade was 37.60%.
What is Eva Renee Barnett's role in Immunovant?
Eva Renee Barnett's role in Immunovant is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.